SLC6A5 and hyperekplexia: Therapeutic management in hyperekplexia might include medication with an allosteric potentiator of the inhibitory GABAA receptor clonazepam in patients with variants in GLRA1 (Tijssen et al. 1997) and SLC6A5 (Bakker et al. 2009; Thomas 2015).